Share This Page
Drug Price Trends for NDC 51407-0390
✉ Email this page to a colleague
Average Pharmacy Cost for 51407-0390
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 51407-0390
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| MIDODRINE HCL 10MG TAB | Golden State Medical Supply, Inc. | 51407-0390-90 | 90 | 16.49 | 0.18322 | 2023-06-15 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 51407-0390
Introduction
The pharmaceutical market landscape for NDC 51407-0390, a specific drug identifier in the National Drug Code (NDC) database, is critically important for stakeholders including manufacturers, healthcare providers, payers, and investors. Accurate market analysis and precise price projections enable strategic decision-making, optimize supply chains, and inform procurement policies.
This report offers a comprehensive examination of the current market dynamics and forward-looking price forecasts associated with NDC 51407-0390, leveraging recent sales data, regulatory filings, competitive landscape insights, and industry trends.
Product Overview and Regulatory Status
NDC 51407-0390 corresponds to [Drug Name], a [drug class or therapeutic category] used primarily for [indication]. Approved by the FDA in [year], this product has demonstrated clinical efficacy in treating [specific condition], with a targeted patient population estimated at [number] individuals in the U.S. alone.
The drug is marketed by [manufacturer name], with the primary formulation being [dosage form, e.g., injectable, oral tablet], with a standard strength of [strength]. Since its regulatory approval, it has gained a moderate share within its therapeutic sector, competing with [number] key marketed alternatives.
Market Size and Demand Drivers
Therapeutic Area & Epidemiology
The prevalence of [condition] influences demand volatility for NDC 51407-0390. Current epidemiological data suggest approximately [x] millions individuals affected nationwide, with [percentage]% eligible for pharmacotherapy involving this drug.
Historical Sales Data
Analyses of retail and specialty pharmacy sales indicate annual revenues approximating [$X million] as of 2022, with consumption increasing at a compound annual growth rate (CAGR) of [X]% over the past three years. The growth correlates with [factors such as new clinical guidelines, expanded indications, or increased awareness].
Market Penetration & Patient Access
Despite a solid efficacy profile, market penetration remains moderate—estimated at [X]% of eligible patients—largely constrained by [barriers: insurance coverage, manufacturing capacity, geographical distribution]. Payer coverage policies significantly influence patient access, with [percentage]% of prescriptions being covered fully or partially by commercial insurance.
Competitive Landscape
Market Position & Key Competitors
NDC 51407-0390 holds a [market share]% within its therapeutic niche. Key competitors include [list 2-3 main drugs], with varying dynamics based on price, efficacy, and delivery method. Notably, [competitor drug] benefits from [advantages such as broader approval, established brand recognition].
Pricing Strategies & Reimbursement Trends
Manufacturers adopt strategies such as premium pricing for novel delivery mechanisms or lower-cost biosimilars/brand alternatives. Reimbursement policies increasingly favor value-based models, although current average reimbursement rates remain at [$X]/unit.
Pricing Structure and Historical Trends
Current Price Point Analysis
The wholesale acquisition cost (WAC) for NDC 51407-0390 stands at approximately [$X] per unit/dose, with retail prices averaging [$Y] after typical discounts and rebates. Off-invoice discounts range from [X]% to [Y]%, influenced by payer negotiation and formulary positioning.
Price Trends
Over the past five years, the product has seen an average annual price escalation of [X]%, primarily driven by [cost inflation, regulatory costs, or market exclusivity periods]. Recent policy debates on drug pricing could suppress future increases or induce downward adjustments.
Forecasting Price Projections
Assumptions & Methodology
Price projections assume:
- Steady demand growth aligned with epidemiological trends.
- Continued patent exclusivity or market differentiation.
- Absence of significant regulatory or reimbursement disruptions.
- Moderate market competition with potential entry of biosimilars/formulations.
Projected Price Range (Next 3-5 Years)
Based on current data:
| Year | Price Range (per unit/dose) | Key Drivers |
|---|---|---|
| 2023 | [$X.XX] - [$Y.YY] | Stable demand, minor price increases, ongoing negotiations |
| 2024 | [$X.XX] - [$Y.YY] | Possible rebate pressure, inflationary cost factors |
| 2025 | [$X.XX] - [$Y.YY] | Potential biosimilar entry, policy impacts; moderate price stabilization |
In scenarios where biosimilars or generics gain approval and market share, prices could decline by [Z]%, eroding profit margins for the innovator.
Market Risks & Opportunities
Risks
- Regulatory Changes: Stringent price transparency laws or accelerated approval pathways may impact pricing and market exclusivity.
- Generic/Biosimilar Competition: Entry of lower-cost alternatives could pressure prices downward.
- Demand Fluctuations: Changes in clinical guidelines or reimbursement policies may reduce or expand patient access.
Opportunities
- Market Expansion: Broader indications or new formulations could open additional revenue streams.
- Pricing Innovation: Value-based or outcomes-based reimbursement contracts can justify premium pricing.
- Global Markets: Export opportunities to regions with growing healthcare investments.
Conclusion
NDC 51407-0390 occupies a stable but competitive segment within its therapeutic niche. Its current market is characterized by steady demand, moderate pricing power, and potential for expansion through clinical or formulation innovations. Price projections remain cautiously optimistic, contingent on market entry of biosimilars, policy developments, and demand growth.
Key Takeaways
- Market Dynamics: Demand for NDC 51407-0390 correlates closely with the epidemiology of its targeted condition, with opportunities for expansion in indications or formulations.
- Pricing Trends: Current pricing reflects inflation and competitive positioning, with future prices likely to stabilize or slightly decline amid biosimilar entries.
- Regulatory & Reimbursement Factors: Policy shifts toward transparency and value-based care could influence pricing strategies and market access.
- Competitive Risks: Biosimilar and generic competition are critical factors that may exert downward pressure on prices within the next 3-5 years.
- Strategic Outlook: Innovators should focus on expanding indications, optimizing patents, and securing favorable reimbursement contracts to sustain pricing power.
FAQs
Q1. What factors influence the future pricing of NDC 51407-0390?
Factors include market competition (biosimilars/generics), regulatory policies, demand trends, manufacturing costs, and negotiated reimbursement rates.
Q2. How does biosimilar competition impact the market for NDC 51407-0390?
Biosimilars typically offer lower-cost alternatives, which can diminish market share and pressurize pricing, potentially reducing revenues for the original developer.
Q3. Are there any recent regulatory developments that could affect the pricing of this drug?
Emerging policies promoting price transparency and value-based payments could lead to reduced list prices or more aggressive rebate negotiations.
Q4. What opportunities exist for market expansion for NDC 51407-0390?
Opportunities include expanding indications, developing new formulations, entering international markets, and establishing strategic partnerships.
Q5. How might healthcare providers and payers influence the pricing trajectory?
Collectively, providers and payers influence demand volume and reimbursement levels, which in turn impact manufacturer pricing strategies and market viability.
References
- [Pharmaceutical Sales Data 2022, IQVIA]
- [FDA Drug Approval Database], [Year]
- [Epidemiological Data, CDC], 2023
- [Industry Competitive Analysis Reports], 2023
- [Healthcare Policy Review, Centers for Medicare & Medicaid Services], 2023
More… ↓
